GRISENDI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 13.620
EU - Europa 7.980
AS - Asia 6.171
SA - Sud America 958
AF - Africa 148
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.935
Nazione #
US - Stati Uniti d'America 13.342
SE - Svezia 2.338
IT - Italia 2.093
SG - Singapore 2.043
CN - Cina 1.478
GB - Regno Unito 1.372
VN - Vietnam 729
HK - Hong Kong 716
BR - Brasile 678
DE - Germania 567
RU - Federazione Russa 312
FI - Finlandia 267
FR - Francia 257
BD - Bangladesh 225
UA - Ucraina 175
TR - Turchia 153
ID - Indonesia 149
KR - Corea 142
CA - Canada 131
IN - India 124
MX - Messico 93
AR - Argentina 91
NL - Olanda 87
BG - Bulgaria 84
IE - Irlanda 61
IQ - Iraq 56
JP - Giappone 56
BE - Belgio 55
AU - Australia 51
PL - Polonia 50
ES - Italia 48
EC - Ecuador 44
ZA - Sudafrica 43
VE - Venezuela 40
PK - Pakistan 34
AE - Emirati Arabi Uniti 32
CL - Cile 30
CO - Colombia 27
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
AL - Albania 23
MY - Malesia 23
AT - Austria 22
LT - Lituania 22
CH - Svizzera 21
MA - Marocco 19
RO - Romania 19
JO - Giordania 18
NP - Nepal 17
SA - Arabia Saudita 16
DZ - Algeria 15
EG - Egitto 15
KE - Kenya 15
PE - Perù 14
PH - Filippine 14
PT - Portogallo 14
IL - Israele 13
IR - Iran 13
UY - Uruguay 13
BZ - Belize 12
OM - Oman 11
PY - Paraguay 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
TN - Tunisia 10
RS - Serbia 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
MD - Moldavia 8
BO - Bolivia 7
BY - Bielorussia 7
LB - Libano 7
PA - Panama 7
SI - Slovenia 7
TH - Thailandia 7
TW - Taiwan 7
SN - Senegal 6
CR - Costa Rica 5
CY - Cipro 5
GR - Grecia 5
JM - Giamaica 5
LK - Sri Lanka 5
MT - Malta 5
SY - Repubblica araba siriana 5
BB - Barbados 4
DK - Danimarca 4
HR - Croazia 4
NG - Nigeria 4
PS - Palestinian Territory 4
AM - Armenia 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
Totale 28.887
Città #
Stockholm 1.795
Ashburn 1.486
Singapore 1.393
Fairfield 1.345
Santa Clara 1.202
Southend 798
Chandler 745
Woodbridge 697
Hong Kong 695
Houston 612
San Jose 575
Seattle 479
Cambridge 437
Ann Arbor 422
Wilmington 420
Nyköping 346
Council Bluffs 335
Hefei 328
Beijing 308
Modena 303
New York 284
London 273
Los Angeles 270
Dearborn 263
Jacksonville 253
Ho Chi Minh City 222
Bologna 214
Helsinki 200
Hanoi 189
Milan 173
The Dalles 161
Chicago 157
Munich 136
Seoul 133
San Diego 130
Jakarta 121
Frankfurt am Main 107
Shanghai 98
Lauterbourg 84
Princeton 84
Moscow 79
Sofia 78
Izmir 77
Dallas 69
Parma 68
Buffalo 66
São Paulo 65
Fremont 63
Orem 62
Eugene 58
Rome 57
Dublin 56
Boardman 52
Salt Lake City 50
Brussels 48
Bremen 42
Phoenix 42
Mexico City 39
Montreal 39
Tokyo 39
Guangzhou 38
Warsaw 37
Reggio Emilia 35
Da Nang 34
Atlanta 33
Nuremberg 33
Chennai 32
Columbus 31
San Giuliano Milanese 31
Falls Church 30
Denver 29
Hillsboro 29
Toronto 27
Haiphong 26
Johannesburg 26
Redwood City 26
Brooklyn 25
Tampa 25
Amsterdam 24
Elk Grove Village 24
Grafing 23
Poplar 23
Rio de Janeiro 23
Manchester 22
Baghdad 21
Des Moines 21
Lancaster 21
Norwalk 21
Ravenna 21
Redondo Beach 21
San Francisco 21
Sydney 21
Portsmouth 20
Tashkent 20
Mumbai 19
Boston 18
Florence 18
Turku 18
Paris 17
Tirana 17
Totale 20.423
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.214
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 500
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 493
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 474
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 447
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 429
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 421
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 421
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 419
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 406
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 392
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 390
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 387
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 380
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 377
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 366
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 364
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 363
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 353
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 353
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 344
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 341
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 336
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 336
Tumor Stroma Manipulation By MSC 330
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 330
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 325
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 324
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 323
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 321
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 317
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 315
Detection of microparticles from human red blood cells by multiparametric flow cytometry 312
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 311
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 309
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 298
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 298
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 298
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 297
GD2 CAR T cells against human glioblastoma 292
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 288
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 284
An adoptive immuno-gene therapy approach targeting neuroblastoma. 281
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 281
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 278
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 277
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 276
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 273
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 268
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 267
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 266
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 265
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 261
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 256
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 250
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 248
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 244
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 243
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 242
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 241
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 241
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 239
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 239
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 237
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 234
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 233
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 232
Cancer stem cells and their microenvironment. 231
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 230
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 229
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 224
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 222
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 219
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 214
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 214
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 210
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 209
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 198
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 197
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 195
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 189
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 188
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 182
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 181
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 173
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 173
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 166
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 165
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 162
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 159
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 152
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 151
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 151
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 151
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 132
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 131
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 128
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 123
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations 116
Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer 102
Totale 29.117
Categoria #
all - tutte 103.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 0 0 130
2021/20222.303 106 321 233 90 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20255.067 144 90 184 372 850 859 501 263 527 254 402 621
2025/202611.220 633 332 669 1.134 1.592 559 1.170 470 2.678 993 719 271
Totale 29.225